Supplement Table 1.
Variability of anticoagulation intensity.
| Characteristics | SDINR | p-Value |
|---|---|---|
| Median (25–75%) | ||
| Age | ||
| <70y | 0.52 (0.37–0.68) | P=0.082 |
| ≥70y | 0.49 (0.36–0.65) | |
| Gender | ||
| Male | 0.50 (0.36–0.66) | P= 0.607 |
| Female | 0.50 (0.37–0.68) | |
| Stroke/TIA/thromboembolism | ||
| Yes | 0.50 (0.36–0.66) | P= 0.740 |
| No | 0.50 (0.37–0.67) | |
| Bleeding history | ||
| Yes | 0.50 (0.40–0.67) | P=0.926 |
| No | 0.50 (0.36–0.67) | |
| Bleeding risk score | ||
| <3 | 0.51 (0.40–0.70) | P=0.099 |
| =3 | 0.50 (0.35–0.66) | |
| >3 | 0.49 (0.37–0.65) | |
| CHA2DS2 – VASc score | ||
| <2 | 0.49 (0.36–0.66) | P=0.497 |
| ≥2 | 0.51 (0.36–0.67) | |
| HAS-BLED score | ||
| ≤2 | 0.50 (0.36–0.66) | P=0.087 |
| >2 | 0.52 (0.38–0.70) | |
TIA – transient ischemic attack. The comparison of the SDINR within subgroups defined by HAS-BLED score, CHA2DS2-VASc score, bleeding risk score, bleeding or stroke/TIA/thromboembolism history, gender, and age (p>0.05)